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Background: This study provides an incipient epidemiological rule using the concept of direct 
method of standardization to determine the genetic link between cancer diseases.
Methods: The overall 8 or 10 years age standardized incidence rate (ASIR) for both cancer 
diseases, for example (A) and (B) should be calculated for all regions of the country. A line 
chart should be used to display the overall ASIR trend of both diseases (A and B). Pearson’s 
correlation can be used to determine the strength of the association between the overall 
ASIRs of both diseases. The overlap or opposite direction of the overall ASIR trend of both 
diseases (A and B) should be determined and studied for possible associations between cancer 
diseases.
Results: If the trend of the overall 8 or 10 years ASIR of a disease (A) follows that of disease 
(B) in all regions of the country, then the genes of patients with both diseases (A and B) will be 
highly homogeneous, and they should be studied in the region with the highest and lowest overall 
ASIR for both diseases (A and B). In addition, if there is an opposite direction or overlapping 
trend for both diseases (A and B) in certain regions of the country or among specific groups of 
people with the same demographic characteristics, then the genes of patients will be investigated 
for both diseases to identify the potential gene link between cancer diseases.
Conclusion: This study revealed that the overall ASIR trends of female breast cancer, prostate 
cancer, and ovarian cancer are very similar in all regions of Saudi Arabia and England. Our 
epidemiological evidence helps to save money, time, and effort for testing the potential gene 
link between cancer diseases.
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Introduction
This study provides a new epidemiological rule to uncover the gene link between cancer 
diseases. The concept of direct method of standardization for calculating the age standard-
ized incidence rate (ASIR) of a disease is the foundation of our epidemiological rule for 
this study. Actually, comparing the morbidity and mortality rates in different regions is an 
essential step in evaluating the health status of an entire population. The crude rates of mor-
bidity and mortality are not suitable for comparison when there are different age structures 
in different populations. Therefore, either direct or indirect methods of standardization can 
be used to control the variables that may otherwise confound the observed relationship. 
However, “age” and “sex” are the most commonly used variables in standardization.1–5
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The gene link was observed between prostate, ovarian, 
and breast cancer through BRCA1 and specifically BRCA2. 
Therefore, if there is a person with prostate cancer and another 
member of his family with breast or ovarian cancer, this could 
be related to the BRCA1 or BRCA2 gene. The lifetime risk of 
these cancer diseases was estimated among individuals who 
have a mutation in BRCA1 and BRCA2. The risk was 40% to 
80% for breast cancer, 11% to 40% for ovarian cancer, and up 
to 39% for prostate cancer.6 However, the main objective of this 
study was to discover a new epidemiological rule that gives the 
best indicator for proving the gene link between cancer diseases. 
Furthermore, our epidemiological rule helps scientists in genet-
ics to investigate a certain region or the appropriate person’s 
characteristics for the gene link between cancer diseases.
Materials and methods
This section provides an overview of the procedures used 
in our epidemiological rule to determine the best group of 
patients for the gene link between cancer diseases. This 
method can be done after calculating the ASIR of cancer 
diseases with different persons’ characteristics. The ASIR 
can be calculated by the direct method of standardization 
which consists of the following steps (Figure 1):
•	 Step 1: calculate the age-specific incidence rate for popu-
lation (A and B).
•	 Step 2: identify the suitable standard population. This 
could be European or World standard population.
•	 Step 3: multiply the proportion of cases by the age group 
of the standard population.
•	 Step 4: calculate ASIR for population (A and B) = total 
proportion of all ages/total standard population.
Our epidemiological rule includes the following stages 
and should be conducted carefully step-by-step:
•	 Stage 1:
	 A: calculate the overall 8 or 10 years ASIR of disease 
(A) in all regions of the country.
	 B: calculate the overall 8 or 10 years ASIR of disease 
(B) in all regions of the country.
	 C: the calculation can be for multiple diseases with 
different persons’ characteristics.
	 D: the method is efficient for long periods (.8 years) 
when calculating ASIR.
•	 Stage 2:
	 A: use the line chart to display the overall ASIR of 
both diseases (A and B).
	 B: check the trends of both diseases (A and B) in all 
regions of the country.
	 C: check the correlation of ASIR of both diseases 
(A and B).
•	 Stage 3:
	 A: if there is a potential relationship between diseases 
(A and B), the trend of the overall ASIRs for both 
diseases will be very similar in all regions of the 
country. This means that there is a gene link between 
both cancer diseases.
	 B: if there is a potential relationship between diseases 
(A and B), the trend of the overall ASIRs for both 
diseases will be similar in all regions of the country 
except one or two areas. The excluded area should 
be investigated for the gene link between both cancer 
diseases.
	 C: if there is no association between diseases (A and B), 
the trend of the overall ASIRs for both diseases will 
not be similar in all regions of the country.
•	 Stage 4:
	 A: investigate the genes of patients with diseases 
(A and B), when the overall ASIRs for both dis-
eases are very high or very low in a certain region 
of the country. The correlation between the overall 
ASIR of the diseases (A and B) is positively strong 
(Figure 2A and B).
	 B: investigate the genes of patients with disease 
(A and B), when there is an opposite direction or over-
lap of the trends for both diseases in a certain region 
of the country. The correlation between the overall 
ASIR of the diseases (A and B) is negatively strong 
(Figure 3A and B).
•	 Stage 5:
	 A: sex adjustment can be applied for the overall 
ASIR of both diseases (A and B). This adjustment 
helps to concentrate the test on a specific sex group 
(Figure 4A and B).
	 B: socioeconomic adjustment can be applied for 
the overall ASIR of both diseases (A and B). This 
adjustment helps to concentrate the gene link test on 
specific socioeconomic groups (Figure 5A and B).
	 C: the adjustment can be done for other persons’ 
characteristics to save time, money, and efforts when 
testing the genes of patients.
•	 Stage 6:
	 A: our epidemiological rule can also be used for a 
single cancer disease with different persons’ char-
acteristics, such as ASIR of stomach cancer among 
males and females.
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Figure 1 An example of direct age adjustment for calculating age standardized incidence rate.
Abbreviation: ASIR, age standardized incidence rate.
	 B: the highest and lowest ASIR of cancer disease 
should be determined in all regions of the particular 
country.
	 C: a case control study should be conducted in the 
area with the highest and lowest ASIR of cancer 
disease.
	 D: the odds ratio of cancer risk factors should be 
calculated in both areas with the highest and lowest 
ASIR.
	 E: make a comparison between the odds ratio of 
cancer risk factors in both areas to justify the real and 
the strongest risk factor of cancer disease.
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Figure 3 The best geographic area for testing the gene link between cancer diseases.
Notes: (A) The overall ASIR of the diseases, for example (disease A and disease B) during an 8-year period. The region number 5 has an opposite direction of the trend for 
both diseases and should be tested for the gene link among patients. The overall ASIR trend of both diseases (A and B) should follow each other in all regions of the country. 
(B) The overall ASIR of the disease (A and B) during an 8-year period. The region number 5 has overlap of the trend for both diseases and should be tested for the gene link 
among patients. The overall ASIR trend of both diseases (A and B) should be similar in all regions of the country.
Abbreviation: ASIR, age standardized incidence rate.
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Figure 2 The best geographic area for testing the gene link between cancer diseases.
Notes: (A) The overall ASIR of the diseases, for example (disease A and disease B) during an 8-year period. The region number 5 has the highest rate for both diseases and 
should be tested for the gene link among patients. The overall ASIR trend of both diseases (A and B) should follow each other in all regions of the country. (B) The overall 
ASIR of the diseases (A and B) during an 8-year period. The region number 5 has the lowest rate for both diseases and should be tested for the gene link among patients. 
The overall ASIR trend of both diseases (A and B) should be similar in all regions of the country.
Abbreviation: ASIR, age standardized incidence rate.
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Figure 4 The best geographic area adjusted by sex for testing the gene link between cancer diseases.
Notes: (A) The overall ASIR of the diseases, for example (disease A and disease B), stratified by sex, during an 8-year period. The region number 5 has the highest trend for 
both diseases among male and female, and should be tested for the gene link in both groups. (B) The overall ASIR of the disease (A and B), stratified by sex, during an 8-year 
period. Female group with disease (B) has different ASIR trend in the region number 5, compared to other groups, the gene link should be investigated for this group.
Abbreviation: ASIR, age standardized incidence rate.
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Figure 5 The best geographic area adjusted by socioeconomic and marital status for testing the gene link between cancer diseases.
Notes: (A) The overall ASIR of the diseases, for example (disease A and disease B), stratified by marital status, during an 8-year period. Single group with disease (A) has different 
ASIR trend in the region number 5, compared to other groups, the gene link should be investigated for this group. (B) The overall ASIR of the disease (A and B), stratified by 
socioeconomic status, during an 8-year period. low socioeconomic group with disease (A) has different ASIR trend in the region number 5, compared to other groups, the gene 
link should be investigated for this group.
Abbreviation: ASIR, age standardized incidence rate.
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Table 1 The ASIR of female breast cancer and prostate cancer 
cases in Saudi Arabia from 2001 to 2008
Year ASIR per 100,000
Female breast cancer Prostate cancer
ASIR per 100,000 women ASIR per 100,000 men
2001 11.8 3.4
2002 12.6 4.0
2003 13.9 4.2
2004 15.4 5.1
2005 18.0 6.2
2006 18.1 6.1
2007 21.6 5.7
2008 19.2 5.7
Abbreviation: ASIR, age standardized incidence rate.
Table 2 The overall ASIR of female breast cancer and prostate 
cancer cases in all regions of Saudi Arabia from 2001 to 2008
Geographic  
area
Overall ASIR per 100,000
Female breast cancer Prostate cancer
Saudi Arabia ASIR per 100,000  
women
ASIR per 100,000 men
Asir 7.3 3.7
Baha 6.1 2.9
Jazan 4.8 1.4
Madinah 11.8 3.0
hail 9.3 2.1
Qassim 13.4 2.6
Riyadh 20.5 7.1
Makkah 19.4 5.2
Najran 8.1 2.0
Jouf 12.4 4.2
Tabuk 15.1 3.0
eastern region 26.6 10.1
Northern region 9.4 3.9
Abbreviation: ASIR, age standardized incidence rate.
Testing the epidemiological rule  
on real data from Saudi Arabia
We calculated the overall ASIR of female breast cancer 
and prostate cancer in Saudi Arabia from 2001 to 2008. 
The ASIR was stratified by the region and year of diag-
nosis (Tables 1 and 2). Our epidemiological rule was 
used to prove the epidemiological association between 
female breast cancer and prostate cancer in Saudi Arabia. 
However, the previously mentioned stages were applied 
step-by-step to check the overall ASIR trend for both 
female breast cancer and prostate cancer in all regions of 
Saudi Arabia.
Testing the epidemiological rule on 
real data from the United Kingdom
We have collected cancer data from the website of United 
Kingdom’s Office for National Statistics, and calculated the 
overall ASIR of female breast cancer, prostate cancer, and 
ovarian cancer from 2003 to 2012 (Table 3). We have tried 
to test our epidemiological rule and prove the association 
between these cancers in all geographic areas of England. 
Furthermore, we independently tested our methods on the 
most common cancers in England, which include esophagus 
cancer, stomach cancer, and pancreatic cancer. The ASIRs 
were stratified by sex to determine the most suited areas to 
discover the real risk factor of cancer disease among males 
and females (Table 4).
Results of the epidemiological rule 
in Saudi Arabia
In this study, we have reported that the overall ASIR trends 
of female breast cancer and prostate cancer were very 
similar and in all regions of Saudi Arabia (Figure 6A). 
Furthermore, our results confirm that the ASIR of female 
breast cancer and prostate cancer stratified by the year of 
diagnosis per 100,000 women and men, indicate a steady 
increase between 2001 and 2008 (Figure 6B). The highest 
overall ASIRs of female breast cancer and prostate cancer 
were observed in the eastern region of Saudi Arabia, while 
the lowest overall rate was recorded in Jazan. However, the 
linear trend for ASIR of female breast cancer and prostate 
cancer was statistically significant from 2001 to 2008, F 
(1, 6) =52,903, P,0.001 and F (1, 6) =18.047, P,0.001. 
Therefore, the equation for a straight line to predict the 
annual ASIR of female breast cancer and prostate cancer 
in Saudi Arabia is:
 10.3 + (1.33 × years) and 3.4 + (0.4 × years). (1)
Results of the epidemiological rule 
in England
The overall ASIR trends of female breast cancer, prostate 
cancer, and ovarian cancer during the years 2003 to 2012, 
were very similar in all regions of England (Figure 7A 
and B). The highest overall ASIRs of female breast can-
cer, prostate cancer, and ovarian cancer were observed in 
the southwest region of England, while the lowest was in 
London. The most common cancers in the United King-
dom were investigated by our epidemiological method to 
identify the best geographic areas for studying the real risk 
factor of cancer disease. The results are mentioned in the 
next sections.
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Table 3 The overall ASIR of female breast cancer, ovarian cancer, and prostate cancer cases in all regions of england from 2003 to 
2012
Geographic area Overall ASIR per 100,000 population
England Female breast cancer Ovarian cancer Prostate cancer
Northeast 132.3 18.3 100.2
Northwest 136.3 19.2 115.0
yorkshire and humber 131.5 17.2 108.8
east Midlands 140.5 20.3 110.5
West Midlands 136.0 18.9 118.8
east of england 134.2 18.9 117.7
london 115.5 14.3 103.8
Southeast 136.7 17.6 112.4
Southwest 147.9 20.9 130.2
Abbreviation: ASIR, age standardized incidence rate.
Table 4 The overall ASIR of esophagus cancer, stomach cancer, and pancreatic cancer among males and females in all regions of 
england from 2003 to 2012
Geographic area Overall ASIR per 100,000 population
Esophagus cancer Stomach cancer Pancreatic cancer
England Male Female Male Female Male Female
Northeast 15.3 6.8 18.4 8.9 12.1 10.8
Northwest 19.4 8.3 16.3 7.7 11.8 10.3
yorkshire and humber 16.3 6.9 16.1 7.5 11.6 9.8
east Midlands 17 7.3 15.2 6.6 12.3 10.2
West Midlands 16.8 7 15.9 6.9 11.6 9.8
east of england 13.7 6.1 13.4 5.4 12.2 10.5
london 12.1 4.9 12.3 5.8 11.3 9.4
Southeast 15.3 6.1 11.2 4.8 11.7 10.5
Southwest 16.2 7.3 12.4 5.7 12.3 10.9
Abbreviation: ASIR, age standardized incidence rate.
esophagus cancer
The overall ASIR trend of esophagus cancer among males 
and females, was very similar in all geographic areas of 
England (Figure 8A). The highest overall ASIR of esopha-
gus cancer among males and females was recorded in the 
northwest region of England, while the lowest was observed 
in London. Furthermore, there was a very strong correla-
tion between male and female esophagus cancer, R=0.96, 
P,0.001.
Stomach cancer
The overall ASIR trend of stomach cancer among males 
and females was also very similar in all geographic areas of 
England (Figure 8B). The highest overall ASIR of stomach 
cancer among males and females was recorded in the 
northeast region of England, while the lowest was observed 
in the southeast. Furthermore, there was a very strong cor-
relation between male and female stomach cancer, R=0.88, 
P,0.001.
Pancreatic cancer
The overall ASIR trend of pancreatic cancer among males 
and females, was very similar in all geographic areas 
of England (Figure 8C). The highest overall ASIR of 
pancreatic cancer among males and females was recorded 
in the southwest region of England, while the lowest being 
observed in London. Furthermore, there was a strong cor-
relation between male and female pancreatic cancer, R=0.80, 
P,0.001.
Discussion
The technique of standardization (either direct or indirect) is 
very important in epidemiology when making comparisons 
between different demographic structures of populations. 
The measures of morbidity and mortality could be misleading 
techniques when comparing populations that differ in their 
age structure. Therefore, standardization helps in adjusting 
confounding variables that distort the results of studies. 
However, we have created a new epidemiological method 
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Figure 6 The ASIR of female breast cancer and prostate cancer adjusted by region and year of diagnosis in Saudi Arabia.
Notes: (A) The overall ASIR of female breast and prostate cancer, stratified by region in Saudi Arabia from 2001 to 2008. This method was tested on real data and proved 
its efficacy to find the best region for the gene link. The eastern region and Jazan were the best places to identify the association between female breast and prostate cancer. 
(B) The overall ASIR of female breast and prostate cancer in Saudi Arabia from 2001 to 2008. The trend of prostate and female breast cancer has the same direction from 
2001 to 2008.
Abbreviation: ASIR, age standardized incidence rate.
that helps genetic scientists to identify the best geographic 
areas to be tested for the gene links of cancer diseases. 
In addition, our epidemiological rule was based on the direct 
method of standardization that we used to calculate the ASIR 
of cancer diseases in different regions of Saudi Arabia and 
the United Kingdom. So, the effectiveness of this rule in 
discovering the potential gene link between cancer diseases 
was proved by using our method.
In this study, we have reported that the overall ASIR 
trend of female breast cancer and prostate cancer was very 
similar in all regions of Saudi Arabia. The overall trend of 
these diseases did not occur by chance in Saudi Arabia dur-
ing the years 2001–2008. Therefore, the actual trends of the 
overall ASIRs for female breast cancer and prostate cancer 
should be similar in all regions and states of the different 
countries. However, we strongly recommend – based on our 
method – to investigate the gene link between female breast 
cancer and prostate cancer in Jazan and the eastern region 
of Saudi Arabia. In the United Kingdom, the results indi-
cated that the overall ASIR trends of female breast cancer, 
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Figure 7 The overall ASIR of female breast cancer, ovarian cancer and prostate cancer adjusted by geographic areas in england, UK.
Notes: (A and B) The overall ASIR of female breast and prostate cancer, stratified by region in England from 2003 to 2012. The data were collected from United Kingdom’s 
Office for National Statistics.
Abbreviation: ASIR, age standardized incidence rate.
prostate cancer, and ovarian cancer were very similar in all 
geographic areas of England. Therefore, we suggest that 
the gene link between these cancer diseases in London and 
southwest region of England be tested. However, for testing 
the gene link of patients in certain regions with multiple 
diseases, it is important to use our epidemiological rule with 
different persons’ characteristics such as sex, marital status, 
socioeconomic status, and race.
Our epidemiological rule proved that the overall ASIR 
trend of esophagus cancer among males and females, from 
2003 to 2012, was very similar in all geographic areas of 
England. Therefore, we strongly recommend the investiga-
tion of the real risk factor of esophagus cancer in London 
and the northwest region of England. This can be done by 
conducting a case control study adjusted by sex in both 
geographical areas. The odds ratio should be compared in 
these regions to identify the real risk factor for esophagus 
cancer. Similarly, the overall ASIR trend of stomach can-
cer among males and females was also very similar in all 
geographic areas of England, with the best area to identify 
the real risk factor of this disease among males and females 
being northeast and southeast England. In addition, the risk 
factor of pancreatic cancer should be observed in London 
and southwest England.
Finally, it is challenging to study the gene link and real 
risk factor of cancer diseases, but through the first step of 
epidemiology, we can interpret the distribution of cancer 
diseases in a population according to time, place, and person. 
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Figure 8 The overall ASIR of esophagus cancer, stomach cancer, and pancreatic cancer adjusted by geographic areas in england, UK.
Notes: (A) The overall ASIR of esophagus cancer among males and females stratified by region in England from 2003 to 2012. (B) The overall ASIR of stomach cancer 
stratified by region in England from 2003 to 2012. (C) The overall ASIR of pancreatic cancer stratified by region in England from 2003 to 2012. The data were collected from 
United Kingdom’s Office for National Statistics.
Abbreviation: ASIR, age standardized incidence rate.
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This will help to generate a new hypothesis for future ana-
lytical observational studies that include case control and 
cohort studies. Both studies can be conducted to identify the 
association between the risk factors and cancer diseases. Fur-
thermore, these analytical studies will help in the prevention 
of cancer diseases by discovering the strongest risk factors 
that attribute to the increase of ASIR in a specific region of 
the country.
Conclusion
This study revealed that the overall ASIR trends of female 
breast cancer, prostate cancer, and ovarian cancer are 
very similar in all regions of Saudi Arabia and United 
Kingdom. The best areas to be tested for the gene link of 
these diseases in Saudi Arabia is the eastern region and 
Jazan while for the United Kingdom, it is London and 
southwest England. The best area in England to be tested 
for the major risk factor of esophagus cancer among males 
and females is London and northwest England, while for 
stomach cancer, the best regions are the northeast and south-
east England. In addition, southwest England and London are 
the best areas for testing the risk factor of pancreatic cancer. 
Our epidemiological rule may help scientists of genetics to iden-
tify the best region for linking the gene of cancer diseases.
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